{"ticker": {"uuid": "cc5f3774-02c4-4c0e-b75f-7bc924c9c293", "symbol": "IXHL", "name": "Incannex Healthcare Ltd ADR", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/incannex-ixhl-secures-u-patent-085433261.html", "source_name": "Insider Monkey", "published_at": "2026-07-15T08:54:33+00:00", "published_display": "15 Jul 2026 08:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare stocks gain favor as State Street up...", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFAxelZmYUVDbndST2xxTTBXVmF6ZThVSjRReEs2LVkxdUpNV2JhSWtaM280bmxvSlVraG1feUZsMjVhNW9fZkljbnFvWlBiTDBxQk5tS3FMRU5PNXNsRkJVWGhQOERSSkZTV1FGcjhNTnY0aTNUdFpJM2JUYw?oc=5", "source_name": "Pluang", "published_at": "2026-07-14T22:37:59+00:00", "published_display": "14 Jul 2026 22:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxORTVDa0ZGMHlqaHRWUkVvWHBZQUNQaUliUXFMM3MwN3FrRXJrckVVN2FNMlg4dVZKajlmTWFPQ1VoeUlCUzJ4WlVqWkt6QmQtcGRPd2puYlVZckNNX0lDVWFKaE5kTEt3M0pySXNsRTlsd3lGNTlMcVA4MmRlZlhRVEcxWkZpTjc1RmtMc3VYeGlzQ2ExRmNRc0lHRnluQ2F2Skt1OWxvNDJUWXM1R1RRSlpuZGRQYmhITjJFelFYTQ?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-14T10:58:35+00:00", "published_display": "14 Jul 2026 10:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector\u2019s 9% Earnings Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnFlY0xtUFY4QVFXSFEzQVRZTVRtaVdRaXFUTlJuRk5TX1BhWTlVVU9sU3psYzQwU2haeTN5OFlNTlFzeHZmN05SRlZHNUVfTzc5VjJuRERSMURsU21Qb1NPai1kWU9TVElIb3B0WGZBQnBSSGdVbDR3YWhVcGZnUUs1NC1KMEpKWG5WU3c2bzlvQ19uLTF0ZjF4cGw2cG8?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-07-12T21:01:30+00:00", "published_display": "12 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Healthcare Stocks Investors Are Turning To As Growth Valuations Look Stretched", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPTVFsVll6aU9hbjRwX2JwYlVPTUJPNGQxRlpLby0yTlVMTlpiSVF0WGM3ek9wUzlDU215OU5uX2NuZkVvUTR6LWZkaXUtM3o3cU0yMmxnTzFmSVZ5NldYS0xVVGV4VEpCcDl2RnVULUh6MmU0OEZWSElJUUZjZ2U5VWdYdzdEVXpseTREZ0FrS1pDQ2Z1aWlnWUJ4V3hOdUFVSGdXZjJrcDk1R3FxX1FOeTJ3VU41ZjM3bkZ6bkRXVXBKRzMxUE9WLVZUZEM?oc=5", "source_name": "Sahm", "published_at": "2026-07-10T19:07:20+00:00", "published_display": "10 Jul 2026 19:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Shine Ahead of Q2 2026 Earnings, Including CVS (CVS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOaVppU2lLZk1kRzM0Q2dGSFB3bEJnRmZhWG14UVM5ZXBxTGtWSkRkZVZLOHpGUy16bmRXQ0JnaElselY3R0hWT0hRdElsc3ZETVFzZUNVVWRmc0xGcmdpcUxLTXF1NExqV0E1QWlYM0luWUFoQ0NiQUd5ck45cUtBMS0yQWNIZWlVOFkxUFBWcjBueS1JclM0OWw4Y1ZuZTJyaTRMRkhLWGMyWG01SmsyVE4wQ0FlZzA5TnhyRDVvTUd1VFBSZDJwMUE4dFVmTUU?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T19:05:48+00:00", "published_display": "10 Jul 2026 19:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNZ1Y4cC05bzdWZlRCWmJtZzBJaC1uSjBMZTEwNkVETU1GRWQ3Z0U0S2E0NERMSnppZ3NkWTZyeElRWUEwaUJmZTl5Rms0dVMyOUdHVWtIdTN2S3FYZ2NuSXlqRi1Bd3R2MFh6aXJmNzZBZUVXWlZlX05XYTJvNGVrYkhRT0pKeXk2OF9Cek1qVzRNWHBsNUc1MGIyQlZ2NFN4Sk1yVG4wdmlBZ2pEUDlPZ19IS3JSbHJiRV9CRHdFX29HMlg4bFR4NmtLZmVDMEtKVUtoVEVxOU1hSWl6Zko2R2JZakJSdjNpTlHSAe8BQVVfeXFMTWlPcmlSbjdRUlYwcFVwUVk0Vkx4eDFsY3BacF9kMFZRcEk0S1JuaXJ2cXdjS2tLeHM4MnlWbzlnVDkxaXlJa3QxbXREdVBldHh5anl6N2hkMUhWMXltVFdkS3Fjcm5GMmxyZ1dHQ05MYS1LZVN5bFduS3RtekwtWWFCamRYYWkzRDYteEFUQXQ5bG5HeGE4T2ZuYVhSTnotSlR1cGxBTlVOTmVROGRHY3F5TG9WT2tnZXRXcWFKNGk4UjB1b25rNHp3QjVTRERhVUVMU2FpRVcxZG43VHJZQkg0VnhoSFdOSUtJQzhPZ0E?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdG51aUpIUmhYREZoTDZDeWpVTXEyYXltS190MFBzWUM5ejlvVWMxN0todjBSM3FUdnRQTDVUTV9yZk1UYkdyZEpaNEFvaG1OYTFBWWc2OE14ZGxwcWlUVmtfbE5tcXdvN0VJNFQ0aGhodDE3MnBRcGYwQmNsci1VamVocG8tQllYYkk2NHNwNXByd3V6Ty1INkhWUWxUUm9YelhwOGZyMVpobm8?oc=5", "source_name": "CNBC", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/incannex-healthcare-receives-us-patent-122604674.html", "source_name": "MT Newswires", "published_at": "2026-06-25T12:26:04+00:00", "published_display": "25 Jun 2026 12:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/incannex-secures-u-patent-grant-120000277.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T12:00:00+00:00", "published_display": "25 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex's sleep apnea drug gets U.S. patent protection to 2040", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPSW51Rll1cVdveDA2bDVCN250V0JxVkVZMjFHSlJtYnJORWlOUlRGOXdmTWdGNzFaNXhfMTNKWGFvQnBvLWZjb3gtWThWRWVpTlNYWlNYOWJtYlRPSklwX1VBcTA3S05sWU5aRGxjRlZqR2tJM0ZMal9YY3pKem16cFcyYVdhTjY1M0VVN2xaMDhnaWVvU0N0RXAwMmtNQUZ6MWpTSzRBd3UtVkJ3ajhRRFRaTmFZNlQyZFYzS0Vn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Healthcare Equipment and Supplies Stocks\u2019 Q1 Earnings: GE HealthCare (NASDAQ:GEHC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQN0VYVjN3QnZTTWNaaldad3g5RTd6b1FleU1kSGJJSE04UFdqYmxjaXRsQkZlZnMxT1BSMnFKaWMyMkU4VV9IT0VZc3dMRmJUVlhMVVRkbmgxV29FN0NXQVpsYmRpUWl6ZmhXaHlSQlJLUTZOOTZQbHRtVEFaaGs1TG8tb2l6Q21fT1pfYVpfSmIyd1BhTXhpR2NWV2YtQzl6enVhYW9rc2VaNUVvUjRVTHBVOEFxN1hKUzRHcjhzbW1xOUxGcmhubk9UQUdHOWRtaWZsSjhNdDdpSTlaSDhwcnd4NXA?oc=5", "source_name": "StockStory", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Incannex Healthcare Inc. Reports Material Event", "summary": "Incannex Healthcare Inc. (IXHL) announced it has secured over A$11.1 million in non-dilutive R&D funding, including A$6.0 million already received and an additional A$5.1 million expected in 2026, through the Australian Government\u2019s Research and Development Tax Incentive Program.", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-8d664815df9e.html", "source_name": "Stock Titan", "published_at": "2026-06-10T17:39:52", "published_display": "10 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare receives A$6m R&D tax incentive payment By Investing.com", "summary": "Incannex Healthcare Inc. (NASDAQ:IXHL) has received A$6,039,162.43 from the Australian Government\u2019s Research and Development Tax Incentive Program and anticipates an additional A$5.1 million in 2026, totaling over A$11.1 million in non-dilutive capital. This funding will support ", "url": "https://uk.investing.com/news/stock-market-news/incannex-healthcare-receives-a6m-rd-tax-incentive-payment-93CH-4721753", "source_name": "Investing.com UK", "published_at": "2026-06-10T13:22:00", "published_display": "10 Jun 2026 13:22", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-receives-6-0-million-120000394.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T12:00:00+00:00", "published_display": "10 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex lines up A$11m in non\u2011dilutive cash to advance IHL\u201142X study", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOZDZGWU01Xzd3ZGxVTG5pQjMtbmFOang0eE9pcmRXaHAybGtCMVVVMUcxYmRqTFVnOWdhOHZUZkZGc3h3RHV0UTlZT3hyYmMtTFV2bnNVY2dBY19OSmZCUUZidmxsZDdGdVFIYlBxMDB4VF9oZHFfV2d6ODJGWS1nS3ZXRnBJZWpQZmsya2psNkZGdjFCbFZYSTZ0M3h5bkp5cHFTT180RF9NYjhYd25VMWhxbEF4X1pBZ2YwMg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (Nasdaq: IXHL) secures over A$11.1M in R&D tax incentives", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQVMxTDEwT0VUZi1lOWszYklpRkxzSG0xVTJEdnFyazI3SXA0aGEyMlpCMTVMNk5mRVlReFE3RjZMSFcyS2I3Qm9NcGRSeG9zd09oMzNLbC1TU3pUallja0c1WEt5ZTN4b1oxYzRfNHJPUWhPSF9YNUJzaUJQcUFzUXE3QlRvcDRtOUliSXNBeXhMQm5JbkZ4eno3MUxJX3h4RXJHTlIxalhPUUJnR1R4azFR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Announces Initiation of Research Coverage by Alliance Global Partners", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-announces-initiation-research-coverage-120000683.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T12:00:00+00:00", "published_display": "09 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alliance Global initiates Incannex (IXHL) equity research coverage on key drug pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQYkU2S1NycERxYkptemV3WUJ1ZVRGWjhOWHY4ZGQzYm5tWDBmVEdIOTJTMU9GVF9SZzZCcGVpMW51X1NmSnd6dzk4U25GV1NuU2JBTnBLS2lnRTY5Mk8wOWZma2d0eFRWVUt6akxOdG4yd3g2X21yOVJhdndWV3VMeV9ULTFTMGFWenhzMEZzcm1JUDlwZVpwTnBSRlg5YV90d2g2U1BEZ0JhcU5SOUl1LWJ3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOa19fS21iRkJZMnR3MkZlN29QRE5wVDZDSWg5RVJ5LXF0WWZpWWlvTHFXU0trNzVleUpvT3JReDZGM0RRdlhUVDNYRmcwU0pMYS01bkZaZURhSGstZzdScThZcjY1SVotQWdxS0RObXVxTGtpM1ZYNXVUWXNPblZHeG1RYUx6dHZXUUFNck8tX19oQ2lOU2swcVBWdy1CTFdZbC0xa0N0RFhNbFpUX0ZXcWM2UDJoSEJCSmFPSUZKRy1EcF9vRGtPUno0aTBEMjJYcUk4Yw?oc=5", "source_name": "Investopedia", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biopharmaceutical company Incannex Healthcare Ltd (IXHL) receives inaugural coverage report from Alliance Global Partners.", "summary": "Alliance Global Partners has initiated coverage on Incannex Healthcare Ltd (IXHL) with a \"Buy\" rating and a target price of $18. This positive outlook from analysts suggests a strong belief in the biopharmaceutical company's future prospects. The report highlights Incannex Health", "url": "https://www.bitget.com/news/detail/12560605449390", "source_name": "Bitget", "published_at": "2026-06-08T17:39:52", "published_display": "08 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Healthcare Providers & Services Stocks\u2019 Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOWE1mb0V1RkxaUjhTeXBkZktWRVotYjBPbmg0QXMtbmJRVlpncWQxazh5LUVnTWNXYVNyT3RReWZyd0cyRmVFSHJiUnpscV91MDlpcWIzWFU5OE9DS09Od18xWGtfd3V6R0FYRWlRV1Z6Q2Vnc2tVRS03VkV4OGFxRzFrTlVGTFBtUnNMN3FuTjZHM0xBdHE0aWRpOVN1Z3hYR3RxM2JySnJrQ0Q1?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (IXHL) launches DReAMzz dose-optimization study of IHL-42X for sleep apnea", "summary": "Incannex Healthcare Inc. has officially commenced its DReAMzz clinical study for IHL-42X, a drug candidate for obstructive sleep apnea (OSA). This crossover dose-optimization trial aims to refine the dosing profile and inform the design of a planned Phase III development program,", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-8f7bfd1b016a.html", "source_name": "Stock Titan", "published_at": "2026-05-17T21:40:01", "published_display": "17 May 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (NASDAQ: IXHL) grows cash to $74.5M amid $16.8M loss", "summary": "Incannex Healthcare Inc. (NASDAQ: IXHL) reported a net loss of $16.8 million for the nine months ended March 31, 2026, though its cash and cash equivalents significantly increased to $74.5 million, up from $15.0 million in June 2025, primarily due to equity financings. The compan", "url": "https://www.stocktitan.net/sec-filings/IXHL/10-q-incannex-healthcare-inc-quarterly-earnings-report-664aae5a3494.html", "source_name": "Stock Titan", "published_at": "2026-05-16T06:39:27", "published_display": "16 May 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Best Healthcare Stocks to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5", "source_name": "Morningstar", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-healthcare-officially-commences-dreamzz-143500032.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T14:35:00+00:00", "published_display": "14 May 2026 14:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. Launches DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea Treatment", "summary": "Incannex Healthcare Inc. has initiated its DReAMzz clinical study for IHL-42X, a treatment for obstructive sleep apnea (OSA). This milestone advances the drug towards late-stage development following positive Phase II results and an FDA Fast Track designation. The study aims to o", "url": "https://www.quiverquant.com/news/Incannex+Healthcare+Inc.+Launches+DReAMzz+Clinical+Study+for+IHL-42X+in+Obstructive+Sleep+Apnea+Treatment", "source_name": "Quiver Quantitative", "published_at": "2026-05-14T14:40:00", "published_display": "14 May 2026 14:40", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex launches DReAMzz study for sleep apnea treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQc3Q0YUFsR0EyaU1BTkhNekJseW9oZ2VmQndLWEpUSWtKSkFmNmRZTDhWOHpQaVJSOVlBa09OMDJaYjdIdzBRVG8zWE9Nak00YlliYTNtWHdYVGt5eFVIazZkRUdxQ3dzOHFfelVSSjA3WlhVcWtWQ3FPWHRBX2RzalYwZXN4RGpNZ2lJUEpXZEdxTFpkdWREUU5kMXpKTmtZNW1wd015enNsR1pvcXdyeWo2MEQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New oral sleep apnea drug IHL-42X wins global MedTech prize", "summary": "Incannex Healthcare (Nasdaq: IXHL) has won the MedTech Breakthrough \u201cBest New Technology Solution for Drug Development\u201d award for its lead candidate, IHL-42X, an oral combination therapy for obstructive sleep apnea (OSA). Phase 2 data for IHL-42X showed statistically significant ", "url": "https://www.stocktitan.net/news/IXHL/incannex-healthcare-wins-med-tech-breakthrough-award-for-ihl-42x-r210tmk4vuff.html", "source_name": "Stock Titan", "published_at": "2026-05-13T05:09:59", "published_display": "13 May 2026 05:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-healthcare-wins-medtech-breakthrough-120000188.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (NASDAQ: IXHL) earns MedTech Breakthrough award for IHL-42X sleep apnea therapy", "summary": "Incannex Healthcare Inc. (NASDAQ: IXHL) has been awarded the \u201cBest New Technology Solution for Drug Development\u201d in the 10th annual MedTech Breakthrough Awards for its lead drug candidate, IHL-42X. This oral fixed-dose combination therapy is being developed for obstructive sleep ", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-720b7aef95b5.html", "source_name": "Stock Titan", "published_at": "2026-05-10T21:40:01", "published_display": "10 May 2026 21:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (NASDAQ:IXHL) Stock Price Up 2.8% - Here's Why", "summary": "Incannex Healthcare (NASDAQ:IXHL) saw its share price rise 2.8% during mid-day trading to $4.75, with approximately 254,209 shares changing hands. Despite the increase, the stock carries a consensus \"Sell\" rating from analysts, including recent downgrades from Weiss Ratings and W", "url": "https://www.marketbeat.com/instant-alerts/incannex-healthcare-nasdaqixhl-stock-price-up-28-heres-why-2026-05-06/", "source_name": "MarketBeat", "published_at": "2026-05-10T21:40:01", "published_display": "10 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (IXHL) Expected to Announce Earnings on Thursday", "summary": "Incannex Healthcare (IXHL) is slated to announce its Q3 2026 earnings on Thursday, May 14th, with analysts anticipating an EPS of ($0.60) and $0.20 million in revenue. The company, a clinical-stage biopharmaceutical firm focusing on cannabinoid and psychedelic therapies, is curre", "url": "https://www.marketbeat.com/instant-alerts/incannex-healthcare-ixhl-expected-to-announce-earnings-on-thursday-2026-05-07/", "source_name": "MarketBeat", "published_at": "2026-05-08T18:08:57", "published_display": "08 May 2026 18:08", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IXHL SEC Filings - Incannex Healthcare Ltd 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive record of Incannex Healthcare (IXHL) SEC filings, including annual, quarterly, and current reports, as well as insider trading forms. Each filing is accompanied by an AI-generated summary, sentiment and impact scores, and end-of-day stock perfor", "url": "https://www.stocktitan.net/sec-filings/IXHL/page-2.html", "source_name": "Stock Titan", "published_at": "2026-05-06T04:09:13", "published_display": "06 May 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Market Pro Likes Healthcare Stocks, Dislikes Software. How He Picks Winners.", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQV3RBY1dlT1ZZbk96N0k1WWpMekF1WFpGOURsWGtBemR0OXJQVUVtS1VJTC1wb3V0WGhJT0ZEV1BlVjhseXJhMDF4YnhabVNfMTBidFZHWmlqdlRxX29HR2VBekx2UVd6dC1PX3BaVUNtNHQ2dzNBSmxnem4tV0haRGExa19WX0ZmaFctRA?oc=5", "source_name": "Barron's", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (NASDAQ: IXHL) links PSX-001 anxiety program to new U.S. psychedelic order", "summary": "Incannex Healthcare Inc. (NASDAQ: IXHL) announced that its PSX-001 oral synthetic psilocybin program for Generalized Anxiety Disorder aligns with a new White House Executive Order aimed at accelerating access to psychedelic treatments for serious mental illness. The company repor", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-1a580668a826.html", "source_name": "Stock Titan", "published_at": "2026-04-25T12:38:44", "published_display": "25 Apr 2026 12:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Healthcare Stocks That Fall Short", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPYmYtNXpYeE9VSUtDbzdkSHo1bVYxWWItd3lmTnNPb0NQalZqR20xN3lJS21PZXA3UThWa1BnSWxqLUVoT0YzdTlrcm01eXZnX1ljRURKMUNIaklrQ0hDbVpfeWVVdzE2bldJYnQ2UWFQSnppR0h4MHJjeEFUaTVpSUNSNFdySUsyLXdSeW1EZmJsVkVkeFRQQ1JYWEY?oc=5", "source_name": "StockStory", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-healthcare-psx-001-program-120000324.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T12:00:00+00:00", "published_display": "22 Apr 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex supports White House order on mental health treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNMlhfd2xGODkwRUxxdjRkdF82RTBGUVdROGc1WWNqWmNFNTExTzJmV01UNDc3SktZV3JQc3ZMN2VwWlVFem5nckd0UWdjcGN5UkJTWTM3N1hVYndUa2pibTFpbktJbGowQWMzVWZkc2l4R21XZERDWkJvcHZUZXgxdVJZSEM2U2czUmUtZjNHNVdHS01mZHRmZnU2R05sUzd3c0hxeFE2WXUtMGRGVzhvdHBRRVlfTFRuTHAzbA?oc=5", "source_name": "Investing.com", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (NASDAQ: IXHL) restarts share buyback, holding $75M cash and no debt", "summary": "Incannex Healthcare (NASDAQ: IXHL) has reactivated its share repurchase program, having already bought back shares, citing a belief that its current market valuation does not accurately reflect its financial strength and clinical progress. The company boasts approximately $75 mil", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-f2c40e693d96.html", "source_name": "Stock Titan", "published_at": "2026-04-13T04:40:48", "published_display": "13 Apr 2026 04:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IXHL Stock Gains As Incannex Reactivates Share Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPa0Z2ZERuQndjUmdwOFNQbUpFa3JVZnBzQnpPNXA4dUNDSWZsS1M5TXlaZm1MMWR4SGNJdnh6ZmNhRl9tLVg3UWU1YVk4TzZLOWhRMV9vVXNJWkdtaW05YWtPRVpReEJkUFFNbXcyRndyVS1Vd1hkVDVTUEF5cndaSG5nbXd2UkU1YVdYV2dWeWc1SGdwdXEyOGFmd1l5OXpYVGdVWmF4RXg3dkcwTXR0SUJhY3o1SURLR1FxeU5xSDltWndq?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research", "summary": "Incannex Healthcare (NASDAQ: IXHL) has partnered with the AASM Foundation to sponsor a 2026 Focused Projects Grant for junior investigators in sleep apnea research, coinciding with Incannex's advancement of its lead investigational oral fixed-dose combination, IHL-42X. The compan", "url": "https://www.stocktitan.net/news/IXHL/incannex-healthcare-announces-partnership-with-the-aasm-foundation-fys9o0u3pei9.html", "source_name": "Stock Titan", "published_at": "2026-03-24T09:09:59", "published_display": "24 Mar 2026 09:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbVFYSHktUzh2VURoNnI2SnFfS21yQVdZM1BZVEkxeUlSQ2todDhqMUJ1VGREdlZmcXlaQjJUVjVodFFfbzZnbVJYVDBFQmJ1QnRUM24tMl9FVm9Yb3U3UWc5OEM4U1ZiOGVkUFVtaktCcnNEZjdqVkt6dzdyN0hWQWtGRVZ0OEhS?oc=5", "source_name": "Barron's", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update", "summary": "Incannex Healthcare Inc. (NASDAQ:IXHL) experienced a significant 96.1% drop in short interest during February, bringing the total to 842,808 shares, which represents about 7.2% of its shares short. Despite analysts maintaining a \"Sell\" rating overall, institutional ownership rema", "url": "https://www.marketbeat.com/instant-alerts/incannex-healthcare-inc-nasdaqixhl-short-interest-update-2026-03-10/", "source_name": "MarketBeat", "published_at": "2026-03-13T12:39:57", "published_display": "13 Mar 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Announces $10 Million Direct Offering", "summary": "Incannex Healthcare Limited (IXHL) announced a $10 million registered direct offering of common stock and warrants to healthcare-focused institutional investors, expected to close around March 13, 2026. The new capital, combined with existing funds, is intended to finance the com", "url": "https://www.theglobeandmail.com/investing/markets/stocks/IXHL/pressreleases/735190/incannex-healthcare-announces-10-million-direct-offering/", "source_name": "The Globe and Mail", "published_at": "2026-03-13T07:46:00", "published_display": "13 Mar 2026 07:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex $10M raise funds DReAMzz Phase 2 trial, preserves Phase 3 cash", "summary": "Incannex Healthcare (Nasdaq: IXHL) has priced a registered direct offering to raise $10 million by issuing 2,000,000 common shares and accompanying warrants. The proceeds are intended to fund the completion of the DReAMzz Phase 2 study for IHL-42X, while existing cash will be pre", "url": "https://www.stocktitan.net/news/IXHL/incannex-healthcare-inc-announces-pricing-of-10-million-registered-99b7qomwc7p3.html", "source_name": "Stock Titan", "published_at": "2026-03-13T03:51:33", "published_display": "13 Mar 2026 03:51", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex plans dose-optimization study for sleep apnea drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNUEJVY0dfdHhZcVFIWXN2TnYxSkExVjExTnctYlJqcUYxaXRWb1htb3NBM3QtUE5rWDVlZ2o1cTZHcGhIQXdyM3k0eDlXcllRb3RlODFMTGUzRjNwZEd1WXVWMlNjNWt1NlNWVFJyS1pFallLNVhTcFg2UmtjTU1rNU9MS3FwbDY4N3o4Q3lYNDFkVFJocWNpMG9OYzY0US1Rbk9VM3Y5NHNZaDU2VTJteGZTLTF6UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX Incannex Healthcare (ASX) A$0.041 -10.87% intraday 10 Mar 2026: watch volume", "summary": "Incannex Healthcare Limited (IHL.AX) experienced significant intraday volatility on March 10, 2026, with its stock price dropping 10.87% to A$0.041 on extremely high trading volume. This movement is attributed to its thin capitalization, recent clinical updates, low liquidity, an", "url": "https://meyka.com/blog/ihlax-incannex-healthcare-asx-a0041-1087-intraday-10-mar-2026-watch-volume-1003/", "source_name": "Meyka", "published_at": "2026-03-10T03:51:33", "published_display": "10 Mar 2026 03:51", "sentiment": "negative", "sentiment_pct": 29, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX Incannex Healthcare (ASX) A$0.041 -10.87% intraday Mar 2026: high volume", "summary": "Incannex Healthcare (IHL.AX) experienced a significant intraday drop of 10.87% to A$0.041 on March 3, 2026, with unusually high trading volume, making it one of ASX's most active stocks. The article highlights the company's financial metrics, clinical pipeline in cannabinoid and ", "url": "https://meyka.com/blog/ihlax-incannex-healthcare-asx-a0041-1087-intraday-mar-2026-high-volume-0203/", "source_name": "Meyka", "published_at": "2026-03-03T23:51:40", "published_display": "03 Mar 2026 23:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. (IXHL) Implements 1-for-30 Reverse Split Effective February 26", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxObHJ3YlBrREYwUEhDcWI4SXdZWnRNR19TZC1qV09id2Q4LU94YUZhZEVsX2d0d0JZOHR3UWVwU2dQdG91OHhGYTRuV2t6Z0xmM1lIa1gzOWtndlhLOGNweVhnR09ZakhKVjNnZXA4TmhQWTNXWkpYb0FtT1lKUGxmNU50LTEtWVZIanotTVl3?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Announces 1-for-30 Reverse Stock Split", "summary": "Incannex Healthcare Limited (IXHL) announced a 1-for-30 reverse stock split of its common stock, effective February 26, 2026, to boost its per-share trading price and regain compliance with Nasdaq's minimum bid price requirement. The split will reduce the share count from approxi", "url": "https://www.theglobeandmail.com/investing/markets/stocks/IXHL/pressreleases/441645/incannex-healthcare-announces-1-for-30-reverse-stock-split/", "source_name": "The Globe and Mail", "published_at": "2026-02-27T07:09:49", "published_display": "27 Feb 2026 07:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Time for Investors to Get Defensive. Sell Staples and Buy Healthcare.", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5tdkc3QW5oYXA5SXA3cC13VlZNaEJVQ3hsaHRLOWU4eHU1WEk3SndtUDhsM1p4Y29kUTdQQ3ZBaWFBOURpSnE1OVdtbmpQMjlwXzBNMWpqY2VvVE5lUjd6ZU1CYXR3aF9mdFgwM3Z3SE1wbHpzV19mbXBxMExhVUk?oc=5", "source_name": "Barron's", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. Announces 1-for-30 Reverse Stock Split to Regain Nasdaq Compliance | IXHL Stock News", "summary": "Incannex Healthcare Inc. announced a 1-for-30 reverse stock split, effective February 26, 2026, to meet Nasdaq's minimum bid price requirement. This action will reduce the outstanding shares from approximately 358 million to 11.9 million, aiming to increase the stock's per-share ", "url": "https://www.quiverquant.com/news/Incannex+Healthcare+Inc.+Announces+1-for-30+Reverse+Stock+Split+to+Regain+Nasdaq+Compliance", "source_name": "Quiver Quantitative", "published_at": "2026-02-25T14:30:00", "published_display": "25 Feb 2026 14:30", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex approves 1-for-30 reverse stock split to meet Nasdaq rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNT09naWVOZENaYkNaM2xXdVI5bW9JZjl6UXRZU0p3ZlB3UW1aemQtc0QyRkJBaWFxQThrZXVDMzlYcmZENnd3aElCWW9Ga0tfdmpDUjJzUEwxSE05cUlubzdHN01MT0F0OEZwb1UwVTQ4dEVkRlgyQ1ZQY0Y2SElSRnZhTUlSSDUyYnc0M25STHZUTnEtbDZwNFJwRXR1RnAtQnFXbjA3akhlZFFFaFBRbU1GblJFRG9SMXZRZTFQMA?oc=5", "source_name": "Investing.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare stock tumbles on reverse stock split news", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQdTdOTDhCR082c3d0MXFMSTNCOUJZUVdLanZyRTF6LWpGVlBmazV4QjRsRnQ1Z3NDNWpLbVNLT0pfNUduek15cWI0ck13Yl9Kck9zQlROendSM0tfLVFTeFhIbTIyeGJEbTFHVXl5UjF1dHo5Q0tkNFBfU0xFU2gyTE5VeGhNSWRjcTlTSm9HOEE2SVdKZEVLV1pBN2pFZ1k0YWJrX1FqX05ad3lOTEhQUmNLYXdnd3cySWRuSGkxY0s?oc=5", "source_name": "Investing.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX stock falls to A$0.041 on heavy volume: what traders should watch next", "summary": "Incannex Healthcare Limited (IHL.AX) stock closed at A$0.041, down 10.87%, with trading volume ten times the 30-day average. The heavy selling pressure and high volatility are attributed to renewed market attention and the company's binary clinical risks in cannabinoids and psych", "url": "https://meyka.com/blog/ihlax-stock-falls-to-a0041-on-heavy-volume-what-traders-should-watch-next-1702/", "source_name": "Meyka", "published_at": "2026-02-22T00:53:24", "published_display": "22 Feb 2026 00:53", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX Incannex Healthcare ASX pre-market 20 Feb 2026: 61.36M shares active", "summary": "Incannex Healthcare (IHL.AX) saw significant pre-market activity on February 20, 2026, with over 61.36 million shares traded, leading to a 10.87% drop in price to A$0.041. This high volume indicates elevated investor attention, primarily driven by the company's clinical pipeline ", "url": "https://meyka.com/blog/ihlax-incannex-healthcare-asx-pre-market-20-feb-2026-6136m-shares-active-1902/", "source_name": "Meyka", "published_at": "2026-02-18T23:52:14", "published_display": "18 Feb 2026 23:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/incannex-ixhl-secures-u-patent-085433261.html", "source_name": "Insider Monkey", "published_at": "2026-07-15T08:54:33+00:00", "published_display": "15 Jul 2026 08:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare stocks gain favor as State Street up...", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFAxelZmYUVDbndST2xxTTBXVmF6ZThVSjRReEs2LVkxdUpNV2JhSWtaM280bmxvSlVraG1feUZsMjVhNW9fZkljbnFvWlBiTDBxQk5tS3FMRU5PNXNsRkJVWGhQOERSSkZTV1FGcjhNTnY0aTNUdFpJM2JUYw?oc=5", "source_name": "Pluang", "published_at": "2026-07-14T22:37:59+00:00", "published_display": "14 Jul 2026 22:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxORTVDa0ZGMHlqaHRWUkVvWHBZQUNQaUliUXFMM3MwN3FrRXJrckVVN2FNMlg4dVZKajlmTWFPQ1VoeUlCUzJ4WlVqWkt6QmQtcGRPd2puYlVZckNNX0lDVWFKaE5kTEt3M0pySXNsRTlsd3lGNTlMcVA4MmRlZlhRVEcxWkZpTjc1RmtMc3VYeGlzQ2ExRmNRc0lHRnluQ2F2Skt1OWxvNDJUWXM1R1RRSlpuZGRQYmhITjJFelFYTQ?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-14T10:58:35+00:00", "published_display": "14 Jul 2026 10:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector\u2019s 9% Earnings Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnFlY0xtUFY4QVFXSFEzQVRZTVRtaVdRaXFUTlJuRk5TX1BhWTlVVU9sU3psYzQwU2haeTN5OFlNTlFzeHZmN05SRlZHNUVfTzc5VjJuRERSMURsU21Qb1NPai1kWU9TVElIb3B0WGZBQnBSSGdVbDR3YWhVcGZnUUs1NC1KMEpKWG5WU3c2bzlvQ19uLTF0ZjF4cGw2cG8?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-07-12T21:01:30+00:00", "published_display": "12 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Healthcare Stocks Investors Are Turning To As Growth Valuations Look Stretched", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPTVFsVll6aU9hbjRwX2JwYlVPTUJPNGQxRlpLby0yTlVMTlpiSVF0WGM3ek9wUzlDU215OU5uX2NuZkVvUTR6LWZkaXUtM3o3cU0yMmxnTzFmSVZ5NldYS0xVVGV4VEpCcDl2RnVULUh6MmU0OEZWSElJUUZjZ2U5VWdYdzdEVXpseTREZ0FrS1pDQ2Z1aWlnWUJ4V3hOdUFVSGdXZjJrcDk1R3FxX1FOeTJ3VU41ZjM3bkZ6bkRXVXBKRzMxUE9WLVZUZEM?oc=5", "source_name": "Sahm", "published_at": "2026-07-10T19:07:20+00:00", "published_display": "10 Jul 2026 19:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Shine Ahead of Q2 2026 Earnings, Including CVS (CVS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOaVppU2lLZk1kRzM0Q2dGSFB3bEJnRmZhWG14UVM5ZXBxTGtWSkRkZVZLOHpGUy16bmRXQ0JnaElselY3R0hWT0hRdElsc3ZETVFzZUNVVWRmc0xGcmdpcUxLTXF1NExqV0E1QWlYM0luWUFoQ0NiQUd5ck45cUtBMS0yQWNIZWlVOFkxUFBWcjBueS1JclM0OWw4Y1ZuZTJyaTRMRkhLWGMyWG01SmsyVE4wQ0FlZzA5TnhyRDVvTUd1VFBSZDJwMUE4dFVmTUU?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T19:05:48+00:00", "published_display": "10 Jul 2026 19:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdG51aUpIUmhYREZoTDZDeWpVTXEyYXltS190MFBzWUM5ejlvVWMxN0todjBSM3FUdnRQTDVUTV9yZk1UYkdyZEpaNEFvaG1OYTFBWWc2OE14ZGxwcWlUVmtfbE5tcXdvN0VJNFQ0aGhodDE3MnBRcGYwQmNsci1VamVocG8tQllYYkk2NHNwNXByd3V6Ty1INkhWUWxUUm9YelhwOGZyMVpobm8?oc=5", "source_name": "CNBC", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/incannex-healthcare-receives-us-patent-122604674.html", "source_name": "MT Newswires", "published_at": "2026-06-25T12:26:04+00:00", "published_display": "25 Jun 2026 12:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/incannex-secures-u-patent-grant-120000277.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T12:00:00+00:00", "published_display": "25 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex's sleep apnea drug gets U.S. patent protection to 2040", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPSW51Rll1cVdveDA2bDVCN250V0JxVkVZMjFHSlJtYnJORWlOUlRGOXdmTWdGNzFaNXhfMTNKWGFvQnBvLWZjb3gtWThWRWVpTlNYWlNYOWJtYlRPSklwX1VBcTA3S05sWU5aRGxjRlZqR2tJM0ZMal9YY3pKem16cFcyYVdhTjY1M0VVN2xaMDhnaWVvU0N0RXAwMmtNQUZ6MWpTSzRBd3UtVkJ3ajhRRFRaTmFZNlQyZFYzS0Vn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Healthcare Equipment and Supplies Stocks\u2019 Q1 Earnings: GE HealthCare (NASDAQ:GEHC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQN0VYVjN3QnZTTWNaaldad3g5RTd6b1FleU1kSGJJSE04UFdqYmxjaXRsQkZlZnMxT1BSMnFKaWMyMkU4VV9IT0VZc3dMRmJUVlhMVVRkbmgxV29FN0NXQVpsYmRpUWl6ZmhXaHlSQlJLUTZOOTZQbHRtVEFaaGs1TG8tb2l6Q21fT1pfYVpfSmIyd1BhTXhpR2NWV2YtQzl6enVhYW9rc2VaNUVvUjRVTHBVOEFxN1hKUzRHcjhzbW1xOUxGcmhubk9UQUdHOWRtaWZsSjhNdDdpSTlaSDhwcnd4NXA?oc=5", "source_name": "StockStory", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Incannex Healthcare Inc. Reports Material Event", "summary": "Incannex Healthcare Inc. (IXHL) announced it has secured over A$11.1 million in non-dilutive R&D funding, including A$6.0 million already received and an additional A$5.1 million expected in 2026, through the Australian Government\u2019s Research and Development Tax Incentive Program.", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-8d664815df9e.html", "source_name": "Stock Titan", "published_at": "2026-06-10T17:39:52", "published_display": "10 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare receives A$6m R&D tax incentive payment By Investing.com", "summary": "Incannex Healthcare Inc. (NASDAQ:IXHL) has received A$6,039,162.43 from the Australian Government\u2019s Research and Development Tax Incentive Program and anticipates an additional A$5.1 million in 2026, totaling over A$11.1 million in non-dilutive capital. This funding will support ", "url": "https://uk.investing.com/news/stock-market-news/incannex-healthcare-receives-a6m-rd-tax-incentive-payment-93CH-4721753", "source_name": "Investing.com UK", "published_at": "2026-06-10T13:22:00", "published_display": "10 Jun 2026 13:22", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-receives-6-0-million-120000394.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T12:00:00+00:00", "published_display": "10 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex lines up A$11m in non\u2011dilutive cash to advance IHL\u201142X study", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOZDZGWU01Xzd3ZGxVTG5pQjMtbmFOang0eE9pcmRXaHAybGtCMVVVMUcxYmRqTFVnOWdhOHZUZkZGc3h3RHV0UTlZT3hyYmMtTFV2bnNVY2dBY19OSmZCUUZidmxsZDdGdVFIYlBxMDB4VF9oZHFfV2d6ODJGWS1nS3ZXRnBJZWpQZmsya2psNkZGdjFCbFZYSTZ0M3h5bkp5cHFTT180RF9NYjhYd25VMWhxbEF4X1pBZ2YwMg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (Nasdaq: IXHL) secures over A$11.1M in R&D tax incentives", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQVMxTDEwT0VUZi1lOWszYklpRkxzSG0xVTJEdnFyazI3SXA0aGEyMlpCMTVMNk5mRVlReFE3RjZMSFcyS2I3Qm9NcGRSeG9zd09oMzNLbC1TU3pUallja0c1WEt5ZTN4b1oxYzRfNHJPUWhPSF9YNUJzaUJQcUFzUXE3QlRvcDRtOUliSXNBeXhMQm5JbkZ4eno3MUxJX3h4RXJHTlIxalhPUUJnR1R4azFR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Announces Initiation of Research Coverage by Alliance Global Partners", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-announces-initiation-research-coverage-120000683.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T12:00:00+00:00", "published_display": "09 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alliance Global initiates Incannex (IXHL) equity research coverage on key drug pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQYkU2S1NycERxYkptemV3WUJ1ZVRGWjhOWHY4ZGQzYm5tWDBmVEdIOTJTMU9GVF9SZzZCcGVpMW51X1NmSnd6dzk4U25GV1NuU2JBTnBLS2lnRTY5Mk8wOWZma2d0eFRWVUt6akxOdG4yd3g2X21yOVJhdndWV3VMeV9ULTFTMGFWenhzMEZzcm1JUDlwZVpwTnBSRlg5YV90d2g2U1BEZ0JhcU5SOUl1LWJ3?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOa19fS21iRkJZMnR3MkZlN29QRE5wVDZDSWg5RVJ5LXF0WWZpWWlvTHFXU0trNzVleUpvT3JReDZGM0RRdlhUVDNYRmcwU0pMYS01bkZaZURhSGstZzdScThZcjY1SVotQWdxS0RObXVxTGtpM1ZYNXVUWXNPblZHeG1RYUx6dHZXUUFNck8tX19oQ2lOU2swcVBWdy1CTFdZbC0xa0N0RFhNbFpUX0ZXcWM2UDJoSEJCSmFPSUZKRy1EcF9vRGtPUno0aTBEMjJYcUk4Yw?oc=5", "source_name": "Investopedia", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biopharmaceutical company Incannex Healthcare Ltd (IXHL) receives inaugural coverage report from Alliance Global Partners.", "summary": "Alliance Global Partners has initiated coverage on Incannex Healthcare Ltd (IXHL) with a \"Buy\" rating and a target price of $18. This positive outlook from analysts suggests a strong belief in the biopharmaceutical company's future prospects. The report highlights Incannex Health", "url": "https://www.bitget.com/news/detail/12560605449390", "source_name": "Bitget", "published_at": "2026-06-08T17:39:52", "published_display": "08 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Healthcare Providers & Services Stocks\u2019 Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOWE1mb0V1RkxaUjhTeXBkZktWRVotYjBPbmg0QXMtbmJRVlpncWQxazh5LUVnTWNXYVNyT3RReWZyd0cyRmVFSHJiUnpscV91MDlpcWIzWFU5OE9DS09Od18xWGtfd3V6R0FYRWlRV1Z6Q2Vnc2tVRS03VkV4OGFxRzFrTlVGTFBtUnNMN3FuTjZHM0xBdHE0aWRpOVN1Z3hYR3RxM2JySnJrQ0Q1?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (IXHL) launches DReAMzz dose-optimization study of IHL-42X for sleep apnea", "summary": "Incannex Healthcare Inc. has officially commenced its DReAMzz clinical study for IHL-42X, a drug candidate for obstructive sleep apnea (OSA). This crossover dose-optimization trial aims to refine the dosing profile and inform the design of a planned Phase III development program,", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-8f7bfd1b016a.html", "source_name": "Stock Titan", "published_at": "2026-05-17T21:40:01", "published_display": "17 May 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (NASDAQ: IXHL) grows cash to $74.5M amid $16.8M loss", "summary": "Incannex Healthcare Inc. (NASDAQ: IXHL) reported a net loss of $16.8 million for the nine months ended March 31, 2026, though its cash and cash equivalents significantly increased to $74.5 million, up from $15.0 million in June 2025, primarily due to equity financings. The compan", "url": "https://www.stocktitan.net/sec-filings/IXHL/10-q-incannex-healthcare-inc-quarterly-earnings-report-664aae5a3494.html", "source_name": "Stock Titan", "published_at": "2026-05-16T06:39:27", "published_display": "16 May 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Best Healthcare Stocks to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5", "source_name": "Morningstar", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-healthcare-officially-commences-dreamzz-143500032.html", "source_name": "GlobeNewswire", "published_at": "2026-05-14T14:35:00+00:00", "published_display": "14 May 2026 14:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. Launches DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea Treatment", "summary": "Incannex Healthcare Inc. has initiated its DReAMzz clinical study for IHL-42X, a treatment for obstructive sleep apnea (OSA). This milestone advances the drug towards late-stage development following positive Phase II results and an FDA Fast Track designation. The study aims to o", "url": "https://www.quiverquant.com/news/Incannex+Healthcare+Inc.+Launches+DReAMzz+Clinical+Study+for+IHL-42X+in+Obstructive+Sleep+Apnea+Treatment", "source_name": "Quiver Quantitative", "published_at": "2026-05-14T14:40:00", "published_display": "14 May 2026 14:40", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex launches DReAMzz study for sleep apnea treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQc3Q0YUFsR0EyaU1BTkhNekJseW9oZ2VmQndLWEpUSWtKSkFmNmRZTDhWOHpQaVJSOVlBa09OMDJaYjdIdzBRVG8zWE9Nak00YlliYTNtWHdYVGt5eFVIazZkRUdxQ3dzOHFfelVSSjA3WlhVcWtWQ3FPWHRBX2RzalYwZXN4RGpNZ2lJUEpXZEdxTFpkdWREUU5kMXpKTmtZNW1wd015enNsR1pvcXdyeWo2MEQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New oral sleep apnea drug IHL-42X wins global MedTech prize", "summary": "Incannex Healthcare (Nasdaq: IXHL) has won the MedTech Breakthrough \u201cBest New Technology Solution for Drug Development\u201d award for its lead candidate, IHL-42X, an oral combination therapy for obstructive sleep apnea (OSA). Phase 2 data for IHL-42X showed statistically significant ", "url": "https://www.stocktitan.net/news/IXHL/incannex-healthcare-wins-med-tech-breakthrough-award-for-ihl-42x-r210tmk4vuff.html", "source_name": "Stock Titan", "published_at": "2026-05-13T05:09:59", "published_display": "13 May 2026 05:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-healthcare-wins-medtech-breakthrough-120000188.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (NASDAQ: IXHL) earns MedTech Breakthrough award for IHL-42X sleep apnea therapy", "summary": "Incannex Healthcare Inc. (NASDAQ: IXHL) has been awarded the \u201cBest New Technology Solution for Drug Development\u201d in the 10th annual MedTech Breakthrough Awards for its lead drug candidate, IHL-42X. This oral fixed-dose combination therapy is being developed for obstructive sleep ", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-720b7aef95b5.html", "source_name": "Stock Titan", "published_at": "2026-05-10T21:40:01", "published_display": "10 May 2026 21:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (NASDAQ:IXHL) Stock Price Up 2.8% - Here's Why", "summary": "Incannex Healthcare (NASDAQ:IXHL) saw its share price rise 2.8% during mid-day trading to $4.75, with approximately 254,209 shares changing hands. Despite the increase, the stock carries a consensus \"Sell\" rating from analysts, including recent downgrades from Weiss Ratings and W", "url": "https://www.marketbeat.com/instant-alerts/incannex-healthcare-nasdaqixhl-stock-price-up-28-heres-why-2026-05-06/", "source_name": "MarketBeat", "published_at": "2026-05-10T21:40:01", "published_display": "10 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (IXHL) Expected to Announce Earnings on Thursday", "summary": "Incannex Healthcare (IXHL) is slated to announce its Q3 2026 earnings on Thursday, May 14th, with analysts anticipating an EPS of ($0.60) and $0.20 million in revenue. The company, a clinical-stage biopharmaceutical firm focusing on cannabinoid and psychedelic therapies, is curre", "url": "https://www.marketbeat.com/instant-alerts/incannex-healthcare-ixhl-expected-to-announce-earnings-on-thursday-2026-05-07/", "source_name": "MarketBeat", "published_at": "2026-05-08T18:08:57", "published_display": "08 May 2026 18:08", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IXHL SEC Filings - Incannex Healthcare Ltd 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive record of Incannex Healthcare (IXHL) SEC filings, including annual, quarterly, and current reports, as well as insider trading forms. Each filing is accompanied by an AI-generated summary, sentiment and impact scores, and end-of-day stock perfor", "url": "https://www.stocktitan.net/sec-filings/IXHL/page-2.html", "source_name": "Stock Titan", "published_at": "2026-05-06T04:09:13", "published_display": "06 May 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Market Pro Likes Healthcare Stocks, Dislikes Software. How He Picks Winners.", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQV3RBY1dlT1ZZbk96N0k1WWpMekF1WFpGOURsWGtBemR0OXJQVUVtS1VJTC1wb3V0WGhJT0ZEV1BlVjhseXJhMDF4YnhabVNfMTBidFZHWmlqdlRxX29HR2VBekx2UVd6dC1PX3BaVUNtNHQ2dzNBSmxnem4tV0haRGExa19WX0ZmaFctRA?oc=5", "source_name": "Barron's", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex (NASDAQ: IXHL) links PSX-001 anxiety program to new U.S. psychedelic order", "summary": "Incannex Healthcare Inc. (NASDAQ: IXHL) announced that its PSX-001 oral synthetic psilocybin program for Generalized Anxiety Disorder aligns with a new White House Executive Order aimed at accelerating access to psychedelic treatments for serious mental illness. The company repor", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-1a580668a826.html", "source_name": "Stock Titan", "published_at": "2026-04-25T12:38:44", "published_display": "25 Apr 2026 12:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Healthcare Stocks That Fall Short", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPYmYtNXpYeE9VSUtDbzdkSHo1bVYxWWItd3lmTnNPb0NQalZqR20xN3lJS21PZXA3UThWa1BnSWxqLUVoT0YzdTlrcm01eXZnX1ljRURKMUNIaklrQ0hDbVpfeWVVdzE2bldJYnQ2UWFQSnppR0h4MHJjeEFUaTVpSUNSNFdySUsyLXdSeW1EZmJsVkVkeFRQQ1JYWEY?oc=5", "source_name": "StockStory", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/incannex-healthcare-psx-001-program-120000324.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T12:00:00+00:00", "published_display": "22 Apr 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex supports White House order on mental health treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNMlhfd2xGODkwRUxxdjRkdF82RTBGUVdROGc1WWNqWmNFNTExTzJmV01UNDc3SktZV3JQc3ZMN2VwWlVFem5nckd0UWdjcGN5UkJTWTM3N1hVYndUa2pibTFpbktJbGowQWMzVWZkc2l4R21XZERDWkJvcHZUZXgxdVJZSEM2U2czUmUtZjNHNVdHS01mZHRmZnU2R05sUzd3c0hxeFE2WXUtMGRGVzhvdHBRRVlfTFRuTHAzbA?oc=5", "source_name": "Investing.com", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare (NASDAQ: IXHL) restarts share buyback, holding $75M cash and no debt", "summary": "Incannex Healthcare (NASDAQ: IXHL) has reactivated its share repurchase program, having already bought back shares, citing a belief that its current market valuation does not accurately reflect its financial strength and clinical progress. The company boasts approximately $75 mil", "url": "https://www.stocktitan.net/sec-filings/IXHL/8-k-incannex-healthcare-inc-reports-material-event-f2c40e693d96.html", "source_name": "Stock Titan", "published_at": "2026-04-13T04:40:48", "published_display": "13 Apr 2026 04:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IXHL Stock Gains As Incannex Reactivates Share Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPa0Z2ZERuQndjUmdwOFNQbUpFa3JVZnBzQnpPNXA4dUNDSWZsS1M5TXlaZm1MMWR4SGNJdnh6ZmNhRl9tLVg3UWU1YVk4TzZLOWhRMV9vVXNJWkdtaW05YWtPRVpReEJkUFFNbXcyRndyVS1Vd1hkVDVTUEF5cndaSG5nbXd2UkU1YVdYV2dWeWc1SGdwdXEyOGFmd1l5OXpYVGdVWmF4RXg3dkcwTXR0SUJhY3o1SURLR1FxeU5xSDltWndq?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research", "summary": "Incannex Healthcare (NASDAQ: IXHL) has partnered with the AASM Foundation to sponsor a 2026 Focused Projects Grant for junior investigators in sleep apnea research, coinciding with Incannex's advancement of its lead investigational oral fixed-dose combination, IHL-42X. The compan", "url": "https://www.stocktitan.net/news/IXHL/incannex-healthcare-announces-partnership-with-the-aasm-foundation-fys9o0u3pei9.html", "source_name": "Stock Titan", "published_at": "2026-03-24T09:09:59", "published_display": "24 Mar 2026 09:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbVFYSHktUzh2VURoNnI2SnFfS21yQVdZM1BZVEkxeUlSQ2todDhqMUJ1VGREdlZmcXlaQjJUVjVodFFfbzZnbVJYVDBFQmJ1QnRUM24tMl9FVm9Yb3U3UWc5OEM4U1ZiOGVkUFVtaktCcnNEZjdqVkt6dzdyN0hWQWtGRVZ0OEhS?oc=5", "source_name": "Barron's", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update", "summary": "Incannex Healthcare Inc. (NASDAQ:IXHL) experienced a significant 96.1% drop in short interest during February, bringing the total to 842,808 shares, which represents about 7.2% of its shares short. Despite analysts maintaining a \"Sell\" rating overall, institutional ownership rema", "url": "https://www.marketbeat.com/instant-alerts/incannex-healthcare-inc-nasdaqixhl-short-interest-update-2026-03-10/", "source_name": "MarketBeat", "published_at": "2026-03-13T12:39:57", "published_display": "13 Mar 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Announces $10 Million Direct Offering", "summary": "Incannex Healthcare Limited (IXHL) announced a $10 million registered direct offering of common stock and warrants to healthcare-focused institutional investors, expected to close around March 13, 2026. The new capital, combined with existing funds, is intended to finance the com", "url": "https://www.theglobeandmail.com/investing/markets/stocks/IXHL/pressreleases/735190/incannex-healthcare-announces-10-million-direct-offering/", "source_name": "The Globe and Mail", "published_at": "2026-03-13T07:46:00", "published_display": "13 Mar 2026 07:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex $10M raise funds DReAMzz Phase 2 trial, preserves Phase 3 cash", "summary": "Incannex Healthcare (Nasdaq: IXHL) has priced a registered direct offering to raise $10 million by issuing 2,000,000 common shares and accompanying warrants. The proceeds are intended to fund the completion of the DReAMzz Phase 2 study for IHL-42X, while existing cash will be pre", "url": "https://www.stocktitan.net/news/IXHL/incannex-healthcare-inc-announces-pricing-of-10-million-registered-99b7qomwc7p3.html", "source_name": "Stock Titan", "published_at": "2026-03-13T03:51:33", "published_display": "13 Mar 2026 03:51", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex plans dose-optimization study for sleep apnea drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNUEJVY0dfdHhZcVFIWXN2TnYxSkExVjExTnctYlJqcUYxaXRWb1htb3NBM3QtUE5rWDVlZ2o1cTZHcGhIQXdyM3k0eDlXcllRb3RlODFMTGUzRjNwZEd1WXVWMlNjNWt1NlNWVFJyS1pFallLNVhTcFg2UmtjTU1rNU9MS3FwbDY4N3o4Q3lYNDFkVFJocWNpMG9OYzY0US1Rbk9VM3Y5NHNZaDU2VTJteGZTLTF6UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX Incannex Healthcare (ASX) A$0.041 -10.87% intraday 10 Mar 2026: watch volume", "summary": "Incannex Healthcare Limited (IHL.AX) experienced significant intraday volatility on March 10, 2026, with its stock price dropping 10.87% to A$0.041 on extremely high trading volume. This movement is attributed to its thin capitalization, recent clinical updates, low liquidity, an", "url": "https://meyka.com/blog/ihlax-incannex-healthcare-asx-a0041-1087-intraday-10-mar-2026-watch-volume-1003/", "source_name": "Meyka", "published_at": "2026-03-10T03:51:33", "published_display": "10 Mar 2026 03:51", "sentiment": "negative", "sentiment_pct": 29, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX Incannex Healthcare (ASX) A$0.041 -10.87% intraday Mar 2026: high volume", "summary": "Incannex Healthcare (IHL.AX) experienced a significant intraday drop of 10.87% to A$0.041 on March 3, 2026, with unusually high trading volume, making it one of ASX's most active stocks. The article highlights the company's financial metrics, clinical pipeline in cannabinoid and ", "url": "https://meyka.com/blog/ihlax-incannex-healthcare-asx-a0041-1087-intraday-mar-2026-high-volume-0203/", "source_name": "Meyka", "published_at": "2026-03-03T23:51:40", "published_display": "03 Mar 2026 23:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. (IXHL) Implements 1-for-30 Reverse Split Effective February 26", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxObHJ3YlBrREYwUEhDcWI4SXdZWnRNR19TZC1qV09id2Q4LU94YUZhZEVsX2d0d0JZOHR3UWVwU2dQdG91OHhGYTRuV2t6Z0xmM1lIa1gzOWtndlhLOGNweVhnR09ZakhKVjNnZXA4TmhQWTNXWkpYb0FtT1lKUGxmNU50LTEtWVZIanotTVl3?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Announces 1-for-30 Reverse Stock Split", "summary": "Incannex Healthcare Limited (IXHL) announced a 1-for-30 reverse stock split of its common stock, effective February 26, 2026, to boost its per-share trading price and regain compliance with Nasdaq's minimum bid price requirement. The split will reduce the share count from approxi", "url": "https://www.theglobeandmail.com/investing/markets/stocks/IXHL/pressreleases/441645/incannex-healthcare-announces-1-for-30-reverse-stock-split/", "source_name": "The Globe and Mail", "published_at": "2026-02-27T07:09:49", "published_display": "27 Feb 2026 07:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Time for Investors to Get Defensive. Sell Staples and Buy Healthcare.", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5tdkc3QW5oYXA5SXA3cC13VlZNaEJVQ3hsaHRLOWU4eHU1WEk3SndtUDhsM1p4Y29kUTdQQ3ZBaWFBOURpSnE1OVdtbmpQMjlwXzBNMWpqY2VvVE5lUjd6ZU1CYXR3aF9mdFgwM3Z3SE1wbHpzV19mbXBxMExhVUk?oc=5", "source_name": "Barron's", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare Inc. Announces 1-for-30 Reverse Stock Split to Regain Nasdaq Compliance | IXHL Stock News", "summary": "Incannex Healthcare Inc. announced a 1-for-30 reverse stock split, effective February 26, 2026, to meet Nasdaq's minimum bid price requirement. This action will reduce the outstanding shares from approximately 358 million to 11.9 million, aiming to increase the stock's per-share ", "url": "https://www.quiverquant.com/news/Incannex+Healthcare+Inc.+Announces+1-for-30+Reverse+Stock+Split+to+Regain+Nasdaq+Compliance", "source_name": "Quiver Quantitative", "published_at": "2026-02-25T14:30:00", "published_display": "25 Feb 2026 14:30", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex approves 1-for-30 reverse stock split to meet Nasdaq rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNT09naWVOZENaYkNaM2xXdVI5bW9JZjl6UXRZU0p3ZlB3UW1aemQtc0QyRkJBaWFxQThrZXVDMzlYcmZENnd3aElCWW9Ga0tfdmpDUjJzUEwxSE05cUlubzdHN01MT0F0OEZwb1UwVTQ4dEVkRlgyQ1ZQY0Y2SElSRnZhTUlSSDUyYnc0M25STHZUTnEtbDZwNFJwRXR1RnAtQnFXbjA3akhlZFFFaFBRbU1GblJFRG9SMXZRZTFQMA?oc=5", "source_name": "Investing.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Incannex Healthcare stock tumbles on reverse stock split news", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQdTdOTDhCR082c3d0MXFMSTNCOUJZUVdLanZyRTF6LWpGVlBmazV4QjRsRnQ1Z3NDNWpLbVNLT0pfNUduek15cWI0ck13Yl9Kck9zQlROendSM0tfLVFTeFhIbTIyeGJEbTFHVXl5UjF1dHo5Q0tkNFBfU0xFU2gyTE5VeGhNSWRjcTlTSm9HOEE2SVdKZEVLV1pBN2pFZ1k0YWJrX1FqX05ad3lOTEhQUmNLYXdnd3cySWRuSGkxY0s?oc=5", "source_name": "Investing.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX stock falls to A$0.041 on heavy volume: what traders should watch next", "summary": "Incannex Healthcare Limited (IHL.AX) stock closed at A$0.041, down 10.87%, with trading volume ten times the 30-day average. The heavy selling pressure and high volatility are attributed to renewed market attention and the company's binary clinical risks in cannabinoids and psych", "url": "https://meyka.com/blog/ihlax-stock-falls-to-a0041-on-heavy-volume-what-traders-should-watch-next-1702/", "source_name": "Meyka", "published_at": "2026-02-22T00:53:24", "published_display": "22 Feb 2026 00:53", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IHL.AX Incannex Healthcare ASX pre-market 20 Feb 2026: 61.36M shares active", "summary": "Incannex Healthcare (IHL.AX) saw significant pre-market activity on February 20, 2026, with over 61.36 million shares traded, leading to a 10.87% drop in price to A$0.041. This high volume indicates elevated investor attention, primarily driven by the company's clinical pipeline ", "url": "https://meyka.com/blog/ihlax-incannex-healthcare-asx-pre-market-20-feb-2026-6136m-shares-active-1902/", "source_name": "Meyka", "published_at": "2026-02-18T23:52:14", "published_display": "18 Feb 2026 23:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 81, "total_relevant": 71, "sentiment_summary": {"positive": 14, "negative": 13, "neutral": 44, "score": 52, "total": 71, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 28.7, "count": 49}, {"event": "earnings", "label": "Earnings", "weight": 6.4, "count": 11}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "capital_return", "label": "Capital return", "weight": 2.0, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 13}, "market_context": {"has_market_context": true, "latest_close": 3.39, "latest_week": "2026-07-10", "one_week_move": -14.6, "four_week_move": -11.5, "twelve_week_move": -7.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.633798, "market_dynamics_buy_signal": false, "relative_strength": -70.240489, "fair_value_gap": -92.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.2378, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-14.6% over one week, -11.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 14}, {"label": "GlobeNewswire", "count": 6}, {"label": "Investing.com", "count": 5}, {"label": "Meyka", "count": 4}, {"label": "StockStory", "count": 3}, {"label": "Market source", "count": 3}, {"label": "MarketBeat", "count": 3}, {"label": "Barron's", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 71}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 49}, {"label": "Earnings", "count": 11}, {"label": "Balance sheet", "count": 4}, {"label": "Capital return", "count": 3}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "71", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "7", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-14.6% over one week, -11.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Incannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X"}], "updated_at": "2026-07-16T13:32:17.548089+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}